- $7.86bn
- $6.39bn
- $15.47bn
- 92
- 62
- 95
- 97
R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,317 | 14,158 | 14,156 | 13,744 | 15,474 |
Cost of Revenue | |||||
Gross Profit | -217 | 400 | 454 | 355 | 477 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 18,389 | 14,154 | 14,502 | 13,500 | 15,327 |
Operating Profit | -1,071 | 3.49 | -346 | 244 | 147 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1,071 | 3.49 | -346 | 244 | 315 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,557 | -12.4 | -366 | 73 | 79 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,522 | -435 | -440 | 145 | 139 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,522 | -435 | -464 | 106 | 83 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -7.78 | -0.063 | -0.793 | 0.444 | 0.542 |
Dividends per Share |